Global Pharma Healthcare Private Limited FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

Global Pharma Healthcare Private Limited has 5 FDA recalls (3 Class I), 1 inspection, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Global Pharma Healthcare Private Limited, the most recent on Oct 20, 2023.

What these totals cover: FDA records filed under the name "Global Pharma Healthcare Private Limited".

Latest recall
D-0488-2023 · Class I · Feb 24, 2023
Latest inspection
Mar 2, 2023 · OAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls5 (3 Class I)Nov 8, 2026File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections1Nov 14, 2026Newest record Nov 5, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

Reviewing Global Pharma Healthcare Private Limited as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Global Pharma Healthcare Private Limited yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Global Pharma Healthcare Private Limited FDA Warning Letters

1 warning letter on Oct 20, 2023.

IssuedSubjectIssuing officeClose-out letter
Oct 20, 2023 · Letter on fda.gov CGMP/Finished Pharmaceuticals/Adulterated/MisbrandedCenter for Drug Evaluation and Research | CDER

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

5 recall records from Jan 30, 2023 to Feb 24, 2023.

NumberClassProductDate
D-0488-2023Class IDelsam Pharma's Artificial Eye Ointment (Mineral Oil 15%, White Petrolatum 83%), 3.5 grams (1/8 oz.)…Feb 24, 2023
D-0922-2023Class IIDelsam Pharma's ARTIFICIAL TEARS (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml…Jan 30, 2023
D-0919-2023Class IArtificial Tears (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1/2 fl oz (15…Jan 30, 2023
D-0921-2023Class IDelsam Pharma's ARTIFICIAL TEARS (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml…Jan 30, 2023
D-0920-2023Class IIArtificial Tears (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1/2 fl oz (15…Jan 30, 2023

Recent FDA inspections

1 inspection on Mar 2, 2023.

DateSiteProductClassificationFEI
Mar 2, 2023Chennai, IndiaDrugsOfficial Action Indicated (OAI)3012323885
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Global Pharma Healthcare Private Limited: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Oct 19, 2023.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3012323885Chennai, India1Mar 2, 2023

Global Pharma Healthcare Private Limited and the FDA: common questions

Has Global Pharma Healthcare Private Limited received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Global Pharma Healthcare Private Limited. The most recent is dated Oct 20, 2023, with the subject "CGMP/Finished Pharmaceuticals/Adulterated/Misbranded".

Has Global Pharma Healthcare Private Limited received an FDA Form 483?

FDA has not published a Form 483 for "Global Pharma Healthcare Private Limited" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Global Pharma Healthcare Private Limited?

The most recent FDA inspection on file ended Mar 2, 2023 at Chennai, India and was classified OAI. FDA has 1 inspection of Global Pharma Healthcare Private Limited on file, 1 of them classified OAI (official action indicated).

Has Global Pharma Healthcare Private Limited had an FDA recall?

Yes. Global Pharma Healthcare Private Limited has 5 FDA recalls on record, 3 of them Class I, the most serious class. The most recent started Feb 24, 2023.

Need more than this page shows? Ask about Global Pharma Healthcare Private Limited in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.